Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-02
2007-01-02
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S165000
Reexamination Certificate
active
10381871
ABSTRACT:
There are provided according to the invention, novel compounds of formula (I)wherein R1, R2, R3, R4, R5, R6, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
REFERENCES:
patent: 5753654 (1998-05-01), Kikuchi et al.
patent: 0760362 (1997-03-01), None
patent: 0031032 (2000-06-01), None
patent: 0035449 (2000-06-01), None
patent: 0035876 (2000-06-01), None
Patent Abstracts of Japan, vol. 016, No. 544, Nov. 13, 1992 & JP04208267, Jul. 29, 1992.
Harada, et. al., “Development of potent serotonin-3 (5-HT3) receptor antagonists. I. Structure-activity relationships of 2-alkoxy-4-amino-5-clorobenzamide derivatives”,Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan, vol. 43, No. 8, 1995, 1364-1378.
Kato, et. al., “Novel benzamides as selective and potent gastrokinetic agents III. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-methoxy-and 2-ethoxy-n-(4-substituted 2-morpholinyl) methyl-benzamides”,Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan, vol. 40, No. 3, Mar. 1992, 652-660.
Kato, et. al., “Novel benzamides as selective and potent gastrokinetic agents 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-n-4-(4-fluorobenzyl)-2-morpholinyl methylbenzamide citrate (as-4370) and related compounds”,Journal of Medicinal Chemistry, American Chemical Society, vol. 34, No. 2, Feb. 1991, 616-624.
Kato, et. al., “Novel benzamides as selective and potent gastrokinetic agents 1. Synthesis and structure-activity relationships of n-(2-morpholinyl) alkylbenzamides”,Journal of Medicinal Chemistry, American Chemical Society, vol. 33, No. 5, May 1990, 1406-1413.
Ancliff Rachael Anne
Cook Caroline Mary
Eldred Colin David
Gore Paul Martin
Harrison Lee Andrew
Anderson Rebecca
Bradney Alice P.
Glaxo Group Limited
Saeed Kamal A.
LandOfFree
Compounds useful in the treatment of inflammatory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds useful in the treatment of inflammatory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful in the treatment of inflammatory diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3769485